Activity |
Description |
Module |
Type |
Day |
Date |
Start |
End |
Room |
Staff |
3927F-Pharmaceutics and Drug Development |
lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
ti |
17 nov 2020 |
8:15 |
9:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
Yang, Mingshi |
3927F-Pharmaceutics and Drug Development |
lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
ti |
17 nov 2020 |
9:15 |
10:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
ti |
17 nov 2020 |
10:15 |
11:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
ti |
17 nov 2020 |
11:15 |
12:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
on |
18 nov 2020 |
9:15 |
10:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
on |
18 nov 2020 |
10:15 |
11:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
on |
18 nov 2020 |
11:15 |
12:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
to |
19 nov 2020 |
9:15 |
10:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
to |
19 nov 2020 |
10:15 |
11:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
to |
19 nov 2020 |
11:15 |
12:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
Activity |
Description |
Module |
Type |
Day |
Date |
Start |
End |
Room |
Staff |
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
ti |
24 nov 2020 |
9:15 |
10:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
ti |
24 nov 2020 |
10:15 |
11:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
ti |
24 nov 2020 |
11:15 |
12:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
on |
25 nov 2020 |
9:15 |
10:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
on |
25 nov 2020 |
10:15 |
11:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
on |
25 nov 2020 |
11:15 |
12:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
to |
26 nov 2020 |
9:15 |
10:15 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
to |
26 nov 2020 |
10:15 |
11:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Lecture |
to |
26 nov 2020 |
11:15 |
12:00 |
Uni-parken - Benzon Auditoriet, Bygn. 12.1.105 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
to |
26 nov 2020 |
12:30 |
16:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
Activity |
Description |
Module |
Type |
Day |
Date |
Start |
End |
Room |
Staff |
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
ma |
30 nov 2020 |
12:30 |
16:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
ti |
1 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
on |
2 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
to |
3 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
Activity |
Description |
Module |
Type |
Day |
Date |
Start |
End |
Room |
Staff |
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
ma |
7 dec 2020 |
12:30 |
16:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
ti |
8 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
on |
9 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
to |
10 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
Activity |
Description |
Module |
Type |
Day |
Date |
Start |
End |
Room |
Staff |
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
ma |
14 dec 2020 |
12:30 |
16:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
ti |
15 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
on |
16 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
to |
17 dec 2020 |
8:30 |
12:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
3927F-Pharmaceutics and Drug Development |
Lab |
3927-B2-2E20;Pharmaceutics and Drug Development |
Laboratorieøvelse |
to |
17 dec 2020 |
12:30 |
16:30 |
Panum - ICMM, Kemi Øvelseslab., Bygn. 8.1.33,Uni-parken - Øv.lokale 131, Bygn. 13.1.131,Uni-parken - Øv.lokale 25, Bygn. 11.1.125 |
|
Activity |
Description |
Module |
Type |
Day |
Date |
Start |
End |
Room |
Staff |
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
ti |
5 jan 2021 |
8:15 |
9:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
ti |
5 jan 2021 |
9:15 |
10:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture/Class |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
ti |
5 jan 2021 |
10:15 |
11:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture/Class |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
ti |
5 jan 2021 |
11:15 |
12:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
on |
6 jan 2021 |
9:15 |
10:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
on |
6 jan 2021 |
10:15 |
11:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
on |
6 jan 2021 |
11:15 |
12:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
to |
7 jan 2021 |
9:15 |
10:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
to |
7 jan 2021 |
10:15 |
11:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
to |
7 jan 2021 |
11:15 |
12:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
to |
7 jan 2021 |
13:15 |
14:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
to |
7 jan 2021 |
14:15 |
15:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
to |
7 jan 2021 |
15:15 |
16:00 |
|
|
Activity |
Description |
Module |
Type |
Day |
Date |
Start |
End |
Room |
Staff |
3927F-harmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
ti |
12 jan 2021 |
9:15 |
10:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture/Class |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
ti |
12 jan 2021 |
10:15 |
11:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture/Class |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
ti |
12 jan 2021 |
11:15 |
12:00 |
|
|
392F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
on |
13 jan 2021 |
9:15 |
10:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
on |
13 jan 2021 |
10:15 |
11:00 |
|
|
3927F-Pharmaceutics and Drug Development |
Lecture |
3927-B2-2E20;Pharmaceutics and Drug Development |
Webinar - Lecture |
on |
13 jan 2021 |
11:15 |
12:00 |
|
|